RBCX Calculation Tool vs HemeOncBuddy

The Spectra Optia® Apheresis System RBCX Calculation Tool is intended to help medical professionals who are responsible for prescribing and performing red blood cell exchange (RBCX) procedures to estimate the volume of replacement fluid required to perform a procedure on the Spectra Optia system. Using the same patient data and the same fluid data that is entered on the Spectra Optia system, the RBCX Calculation Tool calculates and displays the estimated volume of replacement fluid required to achieve the target Hct and FCR. It can also determine whether a custom prime is recommended. While the tool is intended to help prepare for a procedure, it is not intended to be used for making medical decisions. Use of the Spectra Optia® Apheresis System RBCX Calculation Tool on iOS requires iOS version 14.0 or above. For more information about the tool, see the About page.

HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.